New Vitiligo Treatments in 2026: Where Does UVB Phototherapy Fit In?
New Vitiligo Treatments in 2026: Where Does UVB Phototherapy Fit In?
New medications are changing vitiligo treatment in 2026. But does that mean traditional UVB phototherapy is becoming outdated?
Not necessarily. While new treatments offer more options for managing vitiligo, narrowband UVB (NB-UVB) phototherapy remains an established approach for restoring skin pigmentation.
Here's what's new in 2026—and why UVB light therapy still matters.
1. What's New in Vitiligo Treatment in 2026?
One of the biggest developments in recent years has been the introduction of JAK inhibitors, medications that target immune pathways involved in vitiligo.
Two treatments are particularly noteworthy:
-
Opzelura (ruxolitinib cream): FDA-approved in 2022 for non-segmental vitiligo in patients aged 12 and older. It helps promote repigmentation by targeting inflammatory signals in the skin.
-
RINVOQ (upadacitinib): Approved by the European Commission in July 2026 for patients aged 12 and older with non-segmental vitiligo who are candidates for systemic therapy.
These treatments represent important progress, but they are not suitable for everyone. Eligibility, availability, potential side effects, and treatment costs must all be considered.
Most importantly, new medications have not eliminated the need for phototherapy.
2. Why Is UVB Phototherapy Still Important?
Narrowband UVB phototherapy has been used for years to help restore pigmentation in people with vitiligo.
It works by delivering controlled ultraviolet light to affected skin, helping stimulate the activity and migration of pigment-producing cells.
Unlike systemic medications, UVB phototherapy acts directly on the treated skin.
Two commonly discussed approaches are:
311nm Narrowband UVB (NB-UVB)
-
An established treatment for vitiligo.
-
Can be used for localized or more widespread patches.
-
Often requires multiple sessions over several months.
308nm Targeted Phototherapy
-
Excimer lasers and excimer lamps deliver targeted light to smaller areas.
-
May help reduce unnecessary exposure of surrounding skin.
-
Often considered for localized vitiligo.
Portable 308nm LED devices are also available, but they use different light-source technology from excimer lasers. Clinical results from excimer studies should not automatically be assumed to apply to LED devices.
The most appropriate option depends on the location, size, and activity of the vitiligo patches.
3. Can New Medications and UVB Phototherapy Work Together?
This is one of the most interesting areas of recent vitiligo research.
A study published in the Journal of Investigative Dermatology in July 2026 explored combining ruxolitinib cream with NB-UVB phototherapy.
Among participants who added NB-UVB after an insufficient initial response to ruxolitinib cream, researchers observed further improvement in skin repigmentation through week 48.
Although the findings are encouraging, the study was exploratory and relatively small. Larger controlled studies are needed to establish the added benefit of combination treatment.
The key takeaway: Medication and UVB phototherapy may play complementary roles rather than simply replacing one another.
Any combination treatment should be planned and monitored by a dermatologist.
4. What About UVB Phototherapy at Home?
Regular clinic visits can be difficult for people who require treatment several times a week.
This is one reason home UVB phototherapy has attracted increasing interest.
Portable devices may offer practical advantages:
-
More convenient access to scheduled treatment.
-
Less travel to dermatology clinics.
-
Targeted light exposure for selected skin areas.
-
Greater flexibility in following a prescribed treatment plan.
However, home phototherapy still requires medical guidance.
Treatment schedules and UV doses should be determined by a qualified healthcare professional. Appropriate eye protection, careful exposure control, and follow-up assessments are essential to reduce the risk of burns and other adverse effects.
For readers exploring different devices, YOUWEMED offers 311nm NB-UVB and 308nm LED home phototherapy options.
Device selection should be based on professional advice, and results from published phototherapy studies do not necessarily establish the effectiveness of any particular home device.
5. How Long Does Vitiligo Phototherapy Take to Work?
One of the most common questions is: When will my skin color return?
Unfortunately, there is no universal timeline.
NB-UVB treatment often involves two or three sessions per week, with progress assessed over several months. Some patients respond earlier, while others need longer treatment or may see limited improvement.
Results also vary by body area:
-
Face and neck: Often respond relatively well.
-
Trunk and limbs: Response varies.
-
Fingertips, hands, and feet: Often more difficult to repigment.
Consistent treatment and realistic expectations are important. More UV exposure does not necessarily produce better results and may cause skin injury.
6. What's the Best Vitiligo Treatment in 2026?
There is no single treatment that works best for everyone.
New JAK inhibitors have expanded treatment options, while NB-UVB phototherapy remains an important part of vitiligo management. In selected cases, dermatologists may recommend combining different approaches.
The future of vitiligo treatment is not necessarily medication versus phototherapy—it is finding the right combination for each patient.
If you're considering UVB phototherapy at home, start by discussing your treatment options with a dermatologist.
Explore YOUWEMED Home UVB Phototherapy Devices →
References
-
Journal of Investigative Dermatology — Ruxolitinib Cream Combined With NB-UVB Phototherapy (2026)
-
American Academy of Dermatology — Vitiligo Diagnosis and Treatment
Medical Disclaimer: This article is intended for educational purposes only and does not replace professional medical advice. Consult a qualified dermatologist before starting or changing any vitiligo treatment.
